v3.26.1
INCOME TAXES - Schedule of Components of Company's Deferred Income Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carryforward $ 22,897,396 $ 16,979,615
Capitalized pre-business expenses 3,819,778 3,860,144
Research and development credits 1,235,627 1,310,860
Equity method investment 32,669 0
Stock-based compensation 438,028 1,019,432
Accrued expenses 143,978 219,423
Inventory reserve 0 282,905
Operating lease liability 0 57,817
Capitalized 174 research and development costs 980,189 1,966,559
Unrealized derivative gain/loss 0 34,368
Total deferred tax assets before valuation allowance 29,547,665 25,731,123
Less valuation allowance (29,547,665) (25,386,669)
Total deferred tax assets 0 344,454
Deferred tax liabilities    
Fixed assets 0 (295,152)
Right-of-use assets 0 (49,302)
Total deferred tax liabilities 0 (344,454)
Net deferred tax asset (liability) $ 0 $ 0